Transcode Therapeutics Faces Delisting
Transcode Therapeutics receives notice of potential delisting due to failure to meet continued listing standards. The company's stock may be transferred to a different exchange.
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.